These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 37866002)

  • 21. Distinct antigen uptake receptors route to the same storage compartments for cross-presentation in dendritic cells.
    Ho NI; Camps MG; Garcia-Vallejo JJ; Bos E; Koster AJ; Verdoes M; van Kooyk Y; Ossendorp F
    Immunology; 2021 Nov; 164(3):494-506. PubMed ID: 34110622
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Human natural killer cells promote cross-presentation of tumor cell-derived antigens by dendritic cells.
    Deauvieau F; Ollion V; Doffin AC; Achard C; Fonteneau JF; Verronese E; Durand I; Ghittoni R; Marvel J; Dezutter-Dambuyant C; Walzer T; Vie H; Perrot I; Goutagny N; Caux C; Valladeau-Guilemond J
    Int J Cancer; 2015 Mar; 136(5):1085-94. PubMed ID: 25046660
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hepatitis B virus-like particles access major histocompatibility class I and II antigen presentation pathways in primary dendritic cells.
    Moffat JM; Cheong WS; Villadangos JA; Mintern JD; Netter HJ
    Vaccine; 2013 Apr; 31(18):2310-6. PubMed ID: 23473776
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cancer immunotherapy using artificial adjuvant vector cells to deliver NY-ESO-1 antigen to dendritic cells in situ.
    Fujii SI; Yamasaki S; Hanada K; Ueda S; Kawamura M; Shimizu K
    Cancer Sci; 2022 Mar; 113(3):864-874. PubMed ID: 34971473
    [TBL] [Abstract][Full Text] [Related]  

  • 25. IFN-α enhances cross-presentation in human dendritic cells by modulating antigen survival, endocytic routing, and processing.
    Spadaro F; Lapenta C; Donati S; Abalsamo L; Barnaba V; Belardelli F; Santini SM; Ferrantini M
    Blood; 2012 Feb; 119(6):1407-17. PubMed ID: 22184405
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bioinspired vaccines to enhance MHC class-I antigen cross-presentation.
    Baljon JJ; Wilson JT
    Curr Opin Immunol; 2022 Aug; 77():102215. PubMed ID: 35667222
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cross-dressing: an alternative mechanism for antigen presentation.
    Campana S; De Pasquale C; Carrega P; Ferlazzo G; Bonaccorsi I
    Immunol Lett; 2015 Dec; 168(2):349-54. PubMed ID: 26551033
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Rab22a controls MHC-I intracellular trafficking and antigen cross-presentation by dendritic cells.
    Cebrian I; Croce C; Guerrero NA; Blanchard N; Mayorga LS
    EMBO Rep; 2016 Dec; 17(12):1753-1765. PubMed ID: 27861124
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The evolving biology of cross-presentation.
    Ohara RA; Murphy KM
    Semin Immunol; 2023 Mar; 66():101711. PubMed ID: 36645993
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antibody-mediated targeting of antigen to C-type lectin-like receptors Clec9A and Clec12A elicits different vaccination outcomes.
    Macri C; Dumont C; Panozza S; Lahoud MH; Caminschi I; Villadangos JA; Johnston AP; Mintern JD
    Mol Immunol; 2017 Jan; 81():143-150. PubMed ID: 27978488
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The delivery of an antigen from the endocytic compartment into the cytosol for cross-presentation is restricted to early immature dendritic cells.
    Hotta C; Fujimaki H; Yoshinari M; Nakazawa M; Minami M
    Immunology; 2006 Jan; 117(1):97-107. PubMed ID: 16423045
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cytoskeletal regulation of dendritic cells: An intricate balance between migration and presentation for tumor therapy.
    Oliveira MMS; Westerberg LS
    J Leukoc Biol; 2020 Oct; 108(4):1051-1065. PubMed ID: 32557835
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Spatial and mechanistic separation of cross-presentation and endogenous antigen presentation.
    Burgdorf S; Schölz C; Kautz A; Tampé R; Kurts C
    Nat Immunol; 2008 May; 9(5):558-66. PubMed ID: 18376402
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antigen storage compartments in mature dendritic cells facilitate prolonged cytotoxic T lymphocyte cross-priming capacity.
    van Montfoort N; Camps MG; Khan S; Filippov DV; Weterings JJ; Griffith JM; Geuze HJ; van Hall T; Verbeek JS; Melief CJ; Ossendorp F
    Proc Natl Acad Sci U S A; 2009 Apr; 106(16):6730-5. PubMed ID: 19346487
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A role for lipid bodies in the cross-presentation of phagocytosed antigens by MHC class I in dendritic cells.
    Bougnères L; Helft J; Tiwari S; Vargas P; Chang BH; Chan L; Campisi L; Lauvau G; Hugues S; Kumar P; Kamphorst AO; Dumenil AM; Nussenzweig M; MacMicking JD; Amigorena S; Guermonprez P
    Immunity; 2009 Aug; 31(2):232-44. PubMed ID: 19699172
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dendritic cell-mediated cross presentation of tumor-derived peptides is biased against plasma membrane proteins.
    Fessenden TB; Stopfer LE; Chatterjee F; Zulueta J; Mesfin J; Cordero Dumit T; Reijers I; Hoefsmit EP; Blank C; White F; Spranger S
    J Immunother Cancer; 2022 Jul; 10(7):. PubMed ID: 35820727
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Increased expression of HSP70 by colon cancer cells is not always associated with access to the dendritic cell cross-presentation pathway.
    Matera L; Forno S; Galetto A; Moro F; Garetto S; Mussa A
    Cell Mol Biol Lett; 2007; 12(2):268-79. PubMed ID: 17235439
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Trogocytosis of MHC-I/peptide complexes derived from tumors and infected cells enhances dendritic cell cross-priming and promotes adaptive T cell responses.
    Zhang QJ; Li XL; Wang D; Huang XC; Mathis JM; Duan WM; Knight D; Shi R; Glass J; Zhang DQ; Eisenbach L; Jefferies WA
    PLoS One; 2008 Aug; 3(8):e3097. PubMed ID: 18769733
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Route of antigen uptake differentially impacts presentation by dendritic cells and activated monocytes.
    Kamphorst AO; Guermonprez P; Dudziak D; Nussenzweig MC
    J Immunol; 2010 Sep; 185(6):3426-35. PubMed ID: 20729332
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Autophagy-related protein Vps34 controls the homeostasis and function of antigen cross-presenting CD8α
    Parekh VV; Pabbisetty SK; Wu L; Sebzda E; Martinez J; Zhang J; Van Kaer L
    Proc Natl Acad Sci U S A; 2017 Aug; 114(31):E6371-E6380. PubMed ID: 28716903
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.